PMVP — PMV Pharmaceuticals, Inc.

Nasdaq · Health Care · Pharmaceuticals · CIK 1699382 ·
Last close
$1.23
Market Cap
$65.60M
52W High
$1.88
52W Low
$1.21
ADV30
419,126
Next earnings
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule therapies targeting p53 mutations and other p53-related cancers in the United States. It develops rezatapopt, a selective structural corrector of p53 Y220C mutations in Phase 2 clinical trials for tumor agnostic diseases. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Princeton, New Jersey.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 0 -19,019,000 -18,038,000 96,562,000 39,130,000 8,595,000
Dec 2025 0 -19,242,000 -18,037,000 116,562,000 37,983,000 11,850,000
Sep 2025 0 -22,522,000 -21,059,000 133,844,000 36,337,000 12,845,000
Jun 2025 0 -22,879,000 -21,210,000 152,855,000 44,127,000 12,250,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-73,577,000
Investing CF
$70,172,000
Financing CF
$505,000
CapEx
$-86,000
Dividends Paid
Buybacks
EPS Diluted TTM
$-1.52
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-446,454,000
Inventory
Receivables
ST Investments
$74,960,000
EBIT TTM
$-86,207,000
Pretax Income TTM
$-79,914,000
Interest Exp TTM
Analysts
4

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 0 -86,206,000 -77,742,000 116,562,000 11,850,000 -73,577,000
Dec 2024 0 -85,448,000 -58,709,000 191,288,000 15,208,000 -51,282,000
Dec 2023 0 -80,132,000 -68,960,000 252,152,000 26,463,000 -55,657,000
Dec 2022 0 -77,040,000 -73,317,000 270,308,000 24,280,000 -63,760,000
Dec 2021

TTM Snapshot

Revenues TTM
NetIncome TTM
OpCashFlow TTM
Assets (Latest)
Forward EPS
$-1.09

Peers — same industry

TickerNameMarket CapLastDaily %
IMMP IMMUTEP Ltd $66.86M $0.45
MNOV MEDICINOVA INC $67.43M $1.37
RFL Rafael Holdings, Inc. $67.62M $1.32
CING Cingulate Inc. $63.46M $4.78
BYSI BeyondSpring Inc. $63.32M $1.54

News headlines (Yahoo Finance, 1h cache)

12 Health Care Stocks Moving In Wednesday's After-Market Session
2026-05-13 21:06 · Yahoo
PMV Pharmaceuticals Reports First Quarter 2026 Financial Results and Corporate Highlights
2026-05-12 12:00 · Yahoo
PMV Pharmaceuticals Announces Board Chair Transition
2026-04-22 12:00 · Yahoo
Is PMV Pharmaceuticals (NASDAQ:PMVP) In A Good Position To Invest In Growth?
2026-04-20 18:34 · Yahoo
PMV Pharmaceuticals Reports Full Year 2025 Financial Results and Corporate Highlights
2026-03-06 13:00 · Yahoo
New England Journal of Medicine Publishes First-in-Human Rezatapopt Data Showing Selective Reactivation of Mutant p53 in Advanced Solid Tumors
2026-02-26 13:00 · Yahoo
CarMax Stock Down 47% This Past Year, But One Fund Is Betting $6 Million on a Turnaround
2026-02-03 15:20 · Yahoo
Alumis Stock Has Rallied 250% This Past Year. One Fund Sold Its $5 Million Stake Last Quarter.
2026-02-03 15:06 · Yahoo
Caesarstone And 2 More Penny Stocks Worth Watching
2026-01-29 18:05 · Yahoo
Top Penny Stocks To Watch In November 2025
2025-11-18 18:05 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.